Interestingly, three STGs including NRP1, SCARB1, and AXL were demonstrated that their over-expressions were related with the bad prognosis more than the good prognosis of cancer patients, while the down-regulation of ACE2 and TMPRSS2 was exhibited to be more frequently associated with the poor prognosis. This evidence concerns the gene AXL and cancer.